Article reviewed: Exploring the relationship between Parkinson disease and restless legs syndrome

Sleep Medicine

Volumn 4, Issue 2, 2003, Pages 161-162

  Iranzo, Alex ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FERRITIN; HALOPERIDOL; IRON; OPIATE;

AGE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FERRITIN BLOOD LEVEL; HUMAN; INTERVIEW; IRON DEFICIENCY; IRON METABOLISM; IRON THERAPY; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDY; SAMPLE;

EID: 0038748050     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(03)00029-7     Document Type: Article

References (5)

1. Walters AS, Aldrich MA, Allen RP, Anconi-Israel S, et al. Towards a better definition of the restless legs syndrome. Mov Disord 1995;10:634-42.
2. Allen RP, Barker PB, Wehrl F, Song HK, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001;56:263-5.
3. Gorell JM, Ordidge RJ, Brown GG, Sandoni F, et al. Increased iron-related MRI contrast in the substantia nigra ion Parkinson's disease. Neurology 1995;45:1138-43.
4. Lang AE. Restless legs syndrome and Parkinson's disease: insight into pathophysiology. Clin Neuropharmacol 1987;(10):476-8.
5. Tan EK, Lum SY, Wong MC. Restless legs syndrome in Parkinson's disease. J Neurol Sci 2002;196:33-6.